Systemic inflammation mediates the detrimental effects of obesity on asthma control
Allergy and Asthma Proceedings Jan 11, 2018
Zhang X, et al. - This mediation analysis involved the exploration of systemic inflammatory mediators that mediate the impacts of obesity on asthma control. This work corroborated the role of systemic inflammation biomarkers, such as leptin, chemokine (C-C motif) ligand (CCL)17, interleukin (IL)-4, and IL-13, as mediators of the effects of obesity on asthma control.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries